Gift Opening
$200 Off MarketBeat All Access
Thanks for being one of our best subscribers! You are eligible for a limited-time discount.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
Claim Your Discount
×
Free Trial

Sivik Global Healthcare LLC Has $4.03 Million Stock Holdings in Cardinal Health, Inc. (NYSE:CAH)

→ Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad)

Sivik Global Healthcare LLC decreased its holdings in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 33.3% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 40,000 shares of the company's stock after selling 20,000 shares during the quarter. Sivik Global Healthcare LLC's holdings in Cardinal Health were worth $4,032,000 as of its most recent filing with the SEC.

Other institutional investors also recently added to or reduced their stakes in the company. Cornerstone Planning Group LLC bought a new position in shares of Cardinal Health in the 3rd quarter worth $26,000. BKM Wealth Management LLC acquired a new position in Cardinal Health in the fourth quarter valued at about $30,000. Wetzel Investment Advisors Inc. acquired a new stake in Cardinal Health in the fourth quarter valued at about $36,000. Headlands Technologies LLC bought a new position in Cardinal Health in the third quarter valued at about $47,000. Finally, McGlone Suttner Wealth Management Inc. bought a new position in Cardinal Health during the 4th quarter worth $59,000. 87.17% of the stock is owned by institutional investors and hedge funds.

Cardinal Health Stock Performance

Shares of NYSE:CAH traded up $0.12 on Tuesday, reaching $103.03. The company's stock had a trading volume of 2,456,082 shares, compared to its average volume of 2,250,772. The company has a market cap of $25.06 billion, a P/E ratio of 40.57, a PEG ratio of 1.04 and a beta of 0.68. Cardinal Health, Inc. has a 52-week low of $77.56 and a 52-week high of $116.04. The company has a 50-day simple moving average of $109.48 and a 200 day simple moving average of $104.93.


Cardinal Health (NYSE:CAH - Get Free Report) last released its earnings results on Thursday, February 1st. The company reported $1.82 earnings per share for the quarter, topping analysts' consensus estimates of $1.56 by $0.26. Cardinal Health had a negative return on equity of 57.44% and a net margin of 0.30%. The business had revenue of $57.45 billion for the quarter, compared to analyst estimates of $57.02 billion. During the same quarter last year, the firm posted $1.32 earnings per share. The business's revenue was up 11.6% compared to the same quarter last year. On average, equities research analysts forecast that Cardinal Health, Inc. will post 7.28 EPS for the current fiscal year.

Cardinal Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, April 15th. Stockholders of record on Monday, April 1st were given a $0.5006 dividend. The ex-dividend date was Thursday, March 28th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.94%. Cardinal Health's payout ratio is 78.74%.

Wall Street Analyst Weigh In

A number of analysts have commented on the stock. Wells Fargo & Company cut their price target on shares of Cardinal Health from $96.00 to $94.00 and set an "underweight" rating on the stock in a research report on Monday. Barclays initiated coverage on Cardinal Health in a research note on Wednesday, January 3rd. They set an "overweight" rating and a $117.00 price target for the company. SVB Leerink assumed coverage on Cardinal Health in a report on Monday, February 26th. They issued an "outperform" rating and a $125.00 target price for the company. Leerink Partnrs reaffirmed an "outperform" rating on shares of Cardinal Health in a research report on Monday, February 26th. Finally, StockNews.com lowered Cardinal Health from a "strong-buy" rating to a "buy" rating in a report on Wednesday, April 24th. One research analyst has rated the stock with a sell rating, three have given a hold rating and eight have issued a buy rating to the stock. According to data from MarketBeat, Cardinal Health currently has a consensus rating of "Moderate Buy" and an average target price of $102.93.

Check Out Our Latest Report on CAH

Cardinal Health Company Profile

(Free Report)

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

Featured Articles

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

→ 41 banks launch ‘crypto dollar’ (From Stansberry Research) (Ad)

Should you invest $1,000 in Cardinal Health right now?

Before you consider Cardinal Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.

While Cardinal Health currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Featured Articles and Offers

4 Downgraded Stocks Still Worth a Look

4 Downgraded Stocks Still Worth a Look

Despite recent analyst downgrades, these stocks might offer golden opportunities to buy on a dip.

Search Headlines: